Coloplast A/S CLPBY
7.35 USD +0.03 (+0.41%)
Nov 11, 2026, 3:50 PM EST
7.28 Day range 7.35
5.64 52-week range 9.50
- YTD
- -13.53%
- 1 year
- -21.81%
- Market cap
- 16.56B
- EPS (ttm)
- 0.21
- P/E ratio
- 35.00
- YTD return
- -13.53%
- 1-year return
- -21.81%
- Volume
- 42.26K
- Avg volume
- 259.60K
- Open
- 7.28
- Previous close
- 7.32
- Day's range
- 7.28 – 7.35
- 52-week range
- 5.64 – 9.50
- Earnings date
- Aug 18, 2026
5D +0.37 (+5.16%)
Next earnings
Aug 18, 2026
Expected Aug 18, 2026. Consensus EPS estimate 0.10.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 18, 2026 | Jun 30, 2026 | 0.10 | — | — | — |
| May 12, 2026 | Mar 31, 2026 | 0.09 | 0.10 | +0.01 | +11.11% |
| Feb 6, 2026 | Dec 31, 2025 | 0.09 | 0.10 | +0.01 | +11.11% |
| Nov 4, 2025 | Sep 30, 2025 | 0.09465 | 0.07 | -0.02 | -26.04% |
| Aug 19, 2025 | Jun 30, 2025 | 0.0179 | 0.06 | +0.04 | +235.20% |
| May 6, 2025 | Mar 31, 2025 | 0.01384 | 0.06 | +0.05 | +333.53% |
News
Coloplast: Turnaround Is Underway, But Upside Is Limited 
Contrasting Coloplast A/S (OTCMKTS:CLPBY) & Omnicell (NASDAQ:OMCL) 
Coloplast A/S (CLPBY) Q4 2026 Earnings Call Transcript 
Coloplast pares back China operations as market recovery remains elusive 
Coloplast A/S (OTCMKTS:CLPBY) Shares Climb 3.9% – Should You Buy? 
Coloplast A/S (CLPBY) Q3 2026 Earnings Call Transcript 
Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says 
Coloplast Might Have Found Its Bottom 
Coloplast: Went 'BUY' A Bit Early 
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript
Your note
Sign in to keep a note on CLPBY — it syncs with the Stock Master app.